Samar Sheth is a Cardiology physician affiliated with St. Luke's Hospital. OpenAlex indexes 15 publications with 361 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6624 Fannin St
Suite 2320
Houston, TX 770302312
Telephone
832-355-6676Registry record last updated 29 Apr 2017.
Industry payments
53 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202516 payments
- Boston Scientific CorporationProgram year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.2%Beta blocker15.4%Metoprolol Succinate51%Carvedilol22%Metoprolol Tartrate11%Atenolol7%Nebivolol Hcl7%Propranolol Hcl3%Part D<11 patientsStatin14%Atorvastatin Calcium53%Rosuvastatin Calcium37%Simvastatin5%Pravastatin Sodium5%Part D≥107 patients+ 19 more classes in this area
Blood & clotting
13.7%Factor Xa inhibitor7.6%Eliquis73%Xarelto27%Part D≥66 patientsP2Y12 inhibitor5%Clopidogrel91%Prasugrel Hcl9%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
7.3%SGLT2 inhibitor3.6%Jardiance64%Farxiga36%Part D≥24 patientsGLP-1 receptor agonist1.7%Ozempic66%Mounjaro34%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2022 - EARLY OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN PATIENTS WITH PRIOR MEDIASTINAL RADIATION: A PROPENSITY MATCHED ANALYSIS
Journal of the American College of Cardiology
2020 - CALLING FOR SUPPORT: EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) ASSISTED HIGH RISK PERCUTANEOUS CORONARY INTERVENTION OF MULTIVESSEL CORONARY ARTERY DISEASE
Journal of the American College of Cardiology
2020 - PAPILLARY MUSCLE RUPTURE AFTER MYOCARDIAL INFARCTION WITH NON-OBSTRUCTIVE CORONARY ARTERIES
Journal of the American College of Cardiology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Constance Haan, MD
St. Luke's Hospital
Athanasios Fassas
St. Luke's Hospital
Αthanasios Fassas
St. Luke's Hospital
John W Gregory
St. Luke's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”